Publicacións

Publicacións de Eduardo Domínguez Medina

36 resultados

2026

  1. Proof-of-concept study in patient-derived organoids from malignant pleural effusion for functional testing in thoracic tumors

    Biomedicine and Pharmacotherapy, Vol. 203

2025

  1. The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review

    Pharmaceuticals, Vol. 18, Núm. 5

2024

  1. CARTAR: a comprehensive web tool for identifying potential targets in chimeric antigen receptor therapies using TCGA and GTEx data

    Briefings in Bioinformatics, Vol. 25, Núm. 4

  2. Design, synthesis and validation of a new Crimped Head-Piece for DNA-Encoded libraries generation

    Bioorganic and Medicinal Chemistry, Vol. 99

  3. High-Throughput DNA-Encoded Libraries Affinity Selection Platform for Binder Identification with Solid Support Protein Immobilization

    Assay and Drug Development Technologies, Vol. 22, Núm. 4, pp. 192-202

2022

  1. Identification of Sodium Transients Through NaV1.5 Channels as Regulators of Differentiation in Immortalized Dorsal Root Ganglia Neurons

    Frontiers in Cellular Neuroscience, Vol. 16

  2. Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1361-1368

2021

  1. Identification of Novel Regulators of Zalcitabine-Induced Neuropathic Pain

    ACS Chemical Neuroscience, Vol. 12, Núm. 14, pp. 2619-2628

  2. Normalization of DNA encoded library affinity selection results driven by high throughput sequencing and HPLC purification

    Bioorganic and Medicinal Chemistry, Vol. 40

  3. Oligomeric formulas in surgery: A delphi and consensus study

    Nutrients, Vol. 13, Núm. 6

  4. The pi3kδ inhibitor idelalisib diminishes platelet function and shows antithrombotic potential

    International Journal of Molecular Sciences, Vol. 22, Núm. 7

2020

  1. A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling Cascade

    Thrombosis and Haemostasis, Vol. 120, Núm. 2, pp. 262-276

  2. Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds (Nature Communications, (2019), 10, 1, (4731), 10.1038/s41467-019-12888-x)

    Nature Communications

  3. Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy

    Cells, Vol. 9, Núm. 2

  4. Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway

    International Immunopharmacology, Vol. 89

  5. Flux-based assay for the identification of autophagy modulators for osteoarthritis

    Journal of Visualized Experiments, Vol. 2020, Núm. 161, pp. 1-14

2019

  1. Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy

    EBioMedicine, Vol. 45, pp. 588-605

  2. Identification and characterization of Cardiac Glycosides as senolytic compounds

    Nature Communications, Vol. 10, Núm. 1

  3. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

    Cellular and Molecular Gastroenterology and Hepatology, Vol. 7, Núm. 1, pp. 33-53

2018

  1. Role of the inflammation-autophagy-senescence integrative network in Osteoarthritis

    Frontiers in Physiology, Vol. 9, Núm. JUN